Glucose metabolism-related genes with clinicopathological characteristics and prognosis of breast cancer: an analysis based on TCGA database
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 3
Abstract
Objective To investigate the relationship between the expression of LDHA, SLC16A1 and SLC16A3 genes and pathologic features and prognosis in breast cancer. Methods Tissue samples from 1 060 breast cancer patients in The Cancer Genome Atlas (TCGA) were obtained. The association of LDHA, SLC16A1 and SLC16A3 gene expressions with clinicopathological features and prognosis of breast cancer were analyzed. Survival curve were drawn by Kaplan-Meier survival analysis, and univariable and multivariable survival prognosis were analyzed by Cox proportional hazard regression model. Results LDHA expression was associated with distant metastasis (M stage) (χ2=5.560, P=0.018), estrogen receptor (ER) expression (χ2=8.532, P=0.003), and human epidermal growth factor receptor 2 (HER-2) expression (χ2=4.418, P=0.036); SLC16A1 expression correlated with age (χ2=8.040, P=0.005), ER expression (χ2=17.428, P＜0.01), and progesterone receptor (PR) expression (χ2=5.486, P=0.019). SLC16A3 expression correlated with ER expression (χ2=22.447, P＜0.01), PR expression (χ2=20.590, P＜0.01). Patients with high expression of LDHA (χ2=3.856, P=0.049), SLC16A1 (χ2=3.978, P=0.046) and SLC16A3 (χ2=5.008, P=0.025) had lower cumulative survival rates. SLC16A1(HR=1.894, 95%CI: 1.246-2.878, P=0.003) and SLC16A3(HR=1.769, 95%CI: 1.009-2.847, P=0.019) were the independent risk factors for overall survival in breast cancer patients. Conclusion LDHA, SLC16A1 and SLC16A3 are associated with certain pathologic features and poorer prognosis of breast cancer, which may provide new prognostic indicators and therapeutic targets for breast cancer treatment.
Authors and Affiliations
XIA Juanjuan, XU Jingtong, GUAN Xiaoxiang
Keywords
Related Articles
- EP ID EP734502
- DOI 10.13429/j.cnki.cjcr.2024.03.007
- Views 6
- Downloads 0
Influencing factors of pathological complete response in triple-negative breast cancer with neoadjuvant chemotherapy
Objective To analyze the clinical and pathological factors affecting pathological complete response (pCR) of triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NAC). Methods A retrospective analysis wa...
Incidence and risk factors of calf muscular venous thrombosis in patients with severe acute ischemic stroke in NICU
"<b>Objective</b> To investigate the incidence of calf muscular venous thrombosis (CMVT) and analyze its risk factors among patients with severe acute ischemic stroke (AIS) in the Neurological Intensive Care Unit (NICU)...
Expression of LAMP1 and its correlation with clinical prognosis in colorectal cancer
Objective To detect the expression of lysosome-associated membrane protein 1(LAMP1) in colorectal cancer (CRC) and study the relationship between LAMP1 expression and important clinical and pathological indicators of CRC...
Clinical application and research progress of lymphovascular markers for breast cancer
Breast cancer has become the most common malignant tumor in women, and its diagnosis and treatment principles mainly depend on the traditional histological and molecular pathological features. However, the systemic metas...
Hormone levels and clinicopathological features in patients with thyroid cancer complicated with breast cancer
Objective To study the hormone levels and clinicopathological characteristics of patients with thyroid cancer and breast cancer, and to explore the possible relationship between the two cancers. Methods Clinical data of...